Your browser doesn't support javascript.
loading
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Shiovitz, Stacey; Bertagnolli, Monica M; Renfro, Lindsay A; Nam, Eunmi; Foster, Nathan R; Dzieciatkowski, Slavomir; Luo, Yanxin; Lao, Victoria Valinluck; Monnat, Raymond J; Emond, Mary J; Maizels, Nancy; Niedzwiecki, Donna; Goldberg, Richard M; Saltz, Leonard B; Venook, Alan; Warren, Robert S; Grady, William M.
Affiliation
  • Shiovitz S; Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Bertagnolli MM; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
  • Renfro LA; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Nam E; Division of Hematology/Oncology, Ewha Womans University School of Medicine, Seoul, South Korea.
  • Foster NR; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Dzieciatkowski S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Luo Y; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, PR China.
  • Lao VV; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Surgery, University of Washington Medical School, Seattle, Washington.
  • Monnat RJ; Departments of Pathology and Genome Science, University of Washington Medical School, Seattle, Washington.
  • Emond MJ; Department of Biostatistics, University of Washington, Seattle, Washington.
  • Maizels N; Departments of Immunology and Biochemistry, University of Washington, Seattle, Washington.
  • Niedzwiecki D; Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina.
  • Goldberg RM; The Ohio State University, Columbus, OH.
  • Saltz LB; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Venook A; University of California-San Francisco and the Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Warren RS; University of California-San Francisco and the Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Grady WM; Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: wgrady@fhcrc.org.
Gastroenterology ; 147(3): 637-45, 2014 Sep.
Article in En | MEDLINE | ID: mdl-24859205
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / CpG Islands / DNA Methylation Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Gastroenterology Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / CpG Islands / DNA Methylation Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: Gastroenterology Year: 2014 Type: Article